SCHEMBL17261592

SCHEMBL17261592

CCCC(=O)OC(=O)CCC.[CaH2].[NaH]

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.88
▸ CES2 O00748 2/20 0.45
▸ CES1 P23141 2/20 0.45
▸ HDAC3 O15379 4/20 0.43
▸ HDAC1 Q13547 4/20 0.43
▸ HDAC2 Q92769 4/20 0.43
▸ HDAC8 Q9BY41 4/20 0.43
▸ FFAR3 O14843 4/20 0.43
▸ TSHR P16473 2/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.38
▸ CTSD P07339 1/20 0.36
▸ NAAA Q02083 1/20 0.36
▸ DGKA P23743 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ BCL9 O00512 1/20 0.34
▸ CTNNB1 P35222 1/20 0.34
▸ MGAM O43451 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ SI P14410 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28189866 0.97 ALDH1A1 (0.94) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL5144632 0.97 ALDH1A1 (0.94) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL9556715 0.97 ALDH1A1 (0.94) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL8158 0.94 ALDH1A1 (1.00) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL30568759 0.94 ALDH1A1 (1.00) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL10425674 0.92 ALDH1A1 (0.83) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL27743311 0.91 ALDH1A1 (0.94) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL10640242 0.91 ALDH1A1 (0.94) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL28174826 0.91 ALDH1A1 (0.94) ALDH1A1CES2CES1HDAC3HDAC1
SCHEMBL17477083 0.91 ALDH1A1 (0.94) ALDH1A1CES2CES1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12622885-B2 Short chain fatty acid compounds and uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2026-05-12 — — US disclosed
US-20250268851-A1 SHORT CHAIN FATTY ACID COMPOUNDS AND USES THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2025-08-28 — — US disclosed
WO-2025137671-A1 SHORT CHAIN FATTY ACID COMPOUNDS AND USES THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2025-06-26 — — WO disclosed
US-11141391-B2 Biomarkers for risk assessment, diagnosis and target microbiome and intestinal homeostasis for prevention and treatment of amyotrophic lateral sclerosis RUSH UNIVERSITY MEDICAL CENTER (US) 2021-10-12 — — US disclosed
CN-107494980-A One hatching egg feed additive for fowls and its application 盐城六和饲料有限公司 2017-12-22 — — CN disclosed
US-20170296494-A1 Biomarkers for Risk Assessment, Diagnosis and Target Microbiome and Intestinal Homeostasis for Prevention and Treatment of Amyotrophic Lateral Sclerosis RUSH UNIVERSITY MEDICAL CENTER (US) 2017-10-19 — — US disclosed
CN-106107192-A A kind of egg fowl feed additive and application thereof 杭州康德权饲料有限公司 2016-11-16 — — CN disclosed
WO-2015175388-A1 BIOMARKERS FOR RISK ASSESSMENT, DIAGNOSIS AND TARGET MICROBIOME AND INTESTINAL HOMEOSTASIS FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS RUSH UNIVERSITY MEDICAL CENTER (US) 2015-11-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622885-B2 Short chain fatty acid compounds and uses thereof HRH1, H1-0, HLA-DRB1 ALDH1A1 385/4885CES2 2040/4885CES1 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback